MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Relmada Therapeutics, Inc. Common Stock

RLMD

#3115
Relmada Therapeutics, Inc. Common Stock
4.56
+4.59%
Sector:
Base:
Profit Currency:
Daily Range
4.56
4.56
Year Range
0.24
5.12
Daily Change
+4.59%
Monthly Change
+11.22%
6 month change
+570.59%
Year Change
+1588.89%
Previous Close
4.36
Open
4.56
Bid
Ask
Low
4.56
High
4.56
Volume
25
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. RLMD
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
RLMD
2026.01.23
Leerink Partners upgrades Relmada stock to Outperform on bladder cancer treatment potential
Investing Investing
RLMD
2026.01.12
Relmada receives FDA feedback for bladder cancer therapy trials
Seeking Alpha Seeking Alpha
ENGN JNJ URGN RLMD IBRX
2025.12.26
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
Benzinga Benzinga
IVVD RLMD CNTX BKSY-WT
2025.12.22
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - AirJoule Technologies (NASDAQ:AIRJ), BlackSky Technology (NYSE:BKSY)
Investing Investing
RLMD
2025.12.22
Jefferies initiates Relmada Therapeutics stock with Buy rating on pipeline pivot
Investing Investing
RLMD
2025.12.03
Relmada’s bladder cancer therapy shows 92% complete response rate
Investing Investing
RLMD
2025.11.19
Mizuho upgrades Relmada Therapeutics stock to Outperform on NDV-01 potential
Seeking Alpha Seeking Alpha
RLMD
2025.11.14
Relmada Therapeutics, Inc. (RLMD) Q3 2025 Earnings Call Transcript
Investing Investing
DIS PRSO AMAT BLDP BWEN
2025.11.12
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday
Investing Investing
RLMD
2025.11.06
Shenouda, Relmada Therapeutics CFO, buys $1.1m in RLMD
Investing Investing
RLMD
2025.11.06
Relmada therapeutics (RLMD) CEO Sergio Traversa buys $599k in stock
Investing Investing
RLMD
2025.11.06
Relmada Therapeutics (RLMD) COO Kelly buys $198,000 in stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd